LONDON (Reuters) - Drugmaker GlaxoSmithKline, which was slapped with a record $489 million (304.26 million pound) fine for corruption in China last month, said on Tuesday it was looking into allegations of corruption in the United Arab Emirates.
Tuesday 7 October 2014
0 comments:
Post a Comment